Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Status:
Withdrawn
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
To determine whether treatment of patients who have toxic epidermal necrolysis with a drug
called remicaide increases the number of patients who are alive 30 days laters.